The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancerClaudia von Arx, Lucia Del Mastro, Mario Giuliano et al.|Cancer Treatment Reviews|2022Cited by 115
Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcomeLinda Cucciniello, Fabio Puglisi, Giovanna Garufi et al.|Cancer Treatment Reviews|2023Cited by 58
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Grazia Arpino, Letizia Pontolillo et al.|The Breast|2024Cited by 9
Abstract P4-11-08: Comparative analysis of clinician and AI decision making in HR+/HER2- early breast cancerRoberto Buonaiuto, Mario Giuliano, Aldo Caltavituro et al.|Clinical Cancer Research|2025Cited by 1